The safety monitoring specifically tracked thyroid outcomes given the known class concerns
These therapies mimic the action of the endogenous GLP-1 hormone to stimulate insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite, making them highly effective for the management of type 2 diabetes and chronic weight management
Semaglutide is a powerful tool, but its safety profile in the context of autoimmune conditions remains a critical topic
Clinical and Translational Science, 13(6), 1087-1094
Moreover, oral peptides come with a catch: they require much higher quantities of active ingredient than injectables to achieve similar efficacy
Altered Perception of Taste GLP-1s alter your appetite and the way you respond to food, partly through effects on the brain that help you feel satisfied with less